April 29th 2025
Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with rheumatoid arthritis (RA).
Guselkumab Associated With Improved HRQOL, Skin Manifestations in Patients With Psoriasis
September 18th 2021Treatment of guselkumab was found to be safe and effective in improving health-related quality-of-life (HRQOL) and skin manifestations of patients with moderate to severe psoriasis in a real-world setting.
Read More
FDA Committee Votes Against COVID-19 Vaccine Booster for General Population
September 17th 2021The advisory committee voted against COVID-19 vaccine booster shots for individuals 16 years and older, but unanimously voted for booster shots for people 65 years and older or who are at high risk of severe COVID-19.
Read More
Early Life Lower Respiratory Tract Infections May Increase OSA Risk in Children
September 17th 2021Children who experience lower respiratory tract infections early in their lives were shown to be at significantly greater risk of developing obstructive sleep apnea in the first 5 years of life.
Read More
Reducing Disparities, Using AI, Improving Clinical Trials on Tap for PCOC 2021
September 17th 2021At the 10th anniversary meeting of Patient-Centered Oncology Care®, sessions will cover reducing disparities in cancer care, bringing clinical trials closer to the community, and expanding the scope of what the term "precision medicine" means in cancer care.
Read More
Study Clarifies Prevalence and Incidence of SMA in Japan
September 16th 2021An epidemiological investigation of spinal muscular atrophy (SMA) in Japan provided clarity on the genetic condition’s prevalence and incidence in the country and highlighted the importance of newborn screening for SMA
Read More
High OOP Costs for Treatment of Psoriatic Disease Found in Medicare Beneficiaries
September 15th 2021Medicare beneficiaries with psoriasis and psoriatic arthritis were found to pay high annual out-of-pocket (OOP) costs for treatment, which researchers attributed to rising drug prices and reliance on co-insurance for patient cost-sharing.
Read More
Posters Highlight Need for Psychosocial Support in Adolescent Survivors of Childhood Leukemia
September 14th 2021Two posters being presented at the European Society for Medical Oncology Congress 2021 highlighted the need to provide long-term psychosocial support for adolescents who survive childhood leukemia.
Read More
Assessing Lower-Than-Expected Health Care Utilization Trends in Early 2021
September 14th 2021On this episode of Managed Care Cast, we speak with the lead clinician of a study by the Epic Health Research Network and Kaiser Family Foundation, which found that routine medical care and hospital admissions remained below expected levels in the early months of 2021, marking the second consecutive year for such results.
Listen
The general public may not yet need COVID-19 booster doses, according to a new review; a significant incidence of anxiety tied to climate change and government inaction is being reported in young people; COVID-19 infections in US children have increased by approximately 240% since early July.
Read More
Spotlighting Social, Emotional Needs in Underserved Populations With Cancer
September 14th 2021Psychological and emotional needs specific to populations with cancer are often overlooked in clinical research, including those of adolescents, young adults, immigrants, and people of lower socioeconomic status.
Read More
School-Based Vision Program Shown to Improve Short-term Academic Performance in Adolescents
September 10th 2021Students in grades 3 to 7 who were given eyeglasses as part of a school-based vision program were found to achieve better reading scores and exhibit improved academic achievement over 1 year.
Read More
More Focus Needed on Prescribing Disparities for INSTI HIV Treatment
September 10th 2021Data from 2 patient cohorts show that by increasing awareness of such influences as clinic location and patient age and transgender status, gaps in prescription decisions for integrase strand transfer inhibitors (INSTIs) can be lessened.
Read More
A Pharmacist’s Perspective on the Evidence for Lurbinectedin
September 10th 2021David J. Reeves, PharmD, BCOP, of Butler University discusses encouraging results from a recent trial, along with safety questions about the types of patients who weren't studied but are likely to have small cell lung cancer.
Read More
Phase 2 Study Finds Tildrakizumab Effective for PsA Manifestations
September 9th 2021Findings of a phase 2b study indicated that use of tildrakizumab was associated with significant improvements in joint and skin manifestations of patients with psoriatic arthritis (PsA), although improvement in symptoms of dactylitis and enthesitis were not observed.
Read More
Unraveling the Physical, Mental Health Impacts of 9/11, 2 Decades Later: Part 1
September 9th 2021In part 1 of a 2-part series, we look at the current physical and mental health risks first responders and survivors of the 9/11 attacks continue to face, as well as unmet needs that may warrant future intervention.
Read More
The Green Environment, Air Pollution, and Respiratory Health
September 9th 2021Increasing air pollution and climate change have an impact on respiratory health and mortality, explained speakers in 2 sessions on the environment and respiratory diseases at the European Respiratory Society International Congress 2021.
Read More
Back-to-School Virus Watch: Children Are at Risk for More Than Just COVID-19
September 7th 2021Researchers have found that the COVID-19 pandemic has caused potentially millions of children to miss routine vaccines. During a time of back-to-school excitement and reversals of transmission prevention efforts in some states, children may be at risk of facing a slew of non-COVID-19 viral outbreaks.
Read More
Considering Sex and Gender Differences in Respiratory Health
September 7th 2021Health care and research need to do a better job of taking into account sex and gender differences that can affect disease, healthy behaviors, and care delivery, according to speakers at the European Respiratory Society International Congress 2021.
Read More
The Department of Justice vows to protect access to abortions amid restrictive legislation; wide distribution of Pfizer’s COVID-19 booster shot is expected to begin the week of September 20; adult residents from states that lifted eviction moratoriums exhibit increased risk of COVID-19 infection.
Read More
Consumer Data Transparency Is More Important Than Ever as the Battle Against COVID Rages On
September 6th 2021On January 1, CMS implemented the Hospital Price Transparency final rule, but by July, it was clear that many hospitals were noncompliant. Even with a proposed rule for penalties, requirements still only fall on certain parts of the health care industry.
Read More
Promise and Pitfalls of Home Monitoring for Interstitial Lung Disease
September 6th 2021During the pandemic, interest in home monitoring grew, and research has shown it can be feasible for patients with interstitial lung disease, according to a presentation at the European Respiratory Society International Congress 2021.
Read More
Bryn Mawr’s John G. Devlin Jr, MD, Discusses Changing Times in SCLC Treatment and Research
September 6th 2021The chief of medical oncology and hematology at Bryn Mawr Hospital and associate principal investigator for Main Line Health's NCI Community Oncology Research Program discusses therapeutic advances along with ongoing challenges in enrolling patients with small cell lung cancer (SCLC) in clinical trials.
Read More